Logo

GenMark Diagnostics Commences $65M Public Offering of Common Stock

Jun 12, 2017 | staff reporter

NEW YORK (GenomeWeb) – GenMark Diagnostics said after the close of the market on Monday that it has commenced a $65 million public offering of its common stock.

JP Morgan and Bank of America Merrill Lynch are joint book-running managers for the offering.  GenMark noted that it intends to grant the underwriters a 30-day option to purchase up to $9.75 million in additional shares.

The firm said that it intends to use the net proceeds from the offering for general corporate purposes and to fund its commercialization efforts.

Earlier on Monday, GenMark announced it had received 510(k) clearance from the US Food and Drug Administration for its ePlex instrument and Respiratory Pathogen Panel.

Filed under

Business News
Molecular Diagnostics
stock offering
GenMark
Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.